BFC Planning’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
BFC Planning's CLPT Position: Q3 2026 in Review
BFC Planning held its ClearPoint Neuro (CLPT) position steady in Q3 2026 at 2,512 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1805.
BFC Planning first reported a position in CLPT in Q3 2024 and has held it in 9 quarters since. The position peaked at $44.8K in Q2 2026. 95 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.
- BFC Planning held 2,512 shares of ClearPoint Neuro worth $30.7K as of Q3 2026.
- BFC Planning left its ClearPoint Neuro share count unchanged in Q3 2026.
- ClearPoint Neuro made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1805 holding.
- BFC Planning first reported a position in ClearPoint Neuro in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's ClearPoint Neuro position peaked at $44.8K in Q2 2026.
- 95 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.